1-866-647-3279
L-carnitine and its Derivatives
February 21, 2012 By
By: David Miller, BSc, N.D., NHP Scientific Regulatory Associate February 21, 2011 The recent revisions to the status of Levocarnitine in the Canadian regulatory environment (http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/html/sor-dors275-eng.html) have Read More >>
dicentra Special Alert: Schedule F Revisions Published
December 7, 2011 By
Schedule F Revisions Published The long-awaited Schedule F revisions have been published in Canada Gazette II. Amendments to the Food and Drug Regulations have been made to 10 naturally sourced […] Read More >>

    Menu
    Online Learning
    Subscribe

    Stay up to date on regulatory and compliance updates, news, and events!

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions

      *Please note: dicentra and all its subsidiaries only provide cannabis consulting services for business conducted in Canada, to the exclusion of all other countries.